Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Apply
AZD2962
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step